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Abstract
We have previously reported a simple and customizable CRISPR (clustered regularly interspaced short palindromic repeats)
RNA-guided Cas9 nuclease (RGN) system that can be used to efficiently and robustly introduce somatic indel mutations in
endogenous zebrafish genes. Here we demonstrate that RGN-induced mutations are heritable, with efficiencies of germline
transmission reaching as high as 100%. In addition, we extend the power of the RGN system by showing that these
nucleases can be used with single-stranded oligodeoxynucleotides (ssODNs) to create precise intended sequence
modifications, including single nucleotide substitutions. Finally, we describe and validate simple strategies that improve the
targeting range of RGNs from 1 in every 128 basepairs (bps) of random DNA sequence to 1 in every 8 bps. Together, these
advances expand the utility of the CRISPR-Cas system in the zebrafish beyond somatic indel formation to heritable and
precise genome modifications.
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Introduction
Genome engineering represents a significant bottleneck for the
utility of some of the most important biomedical model organisms,
such as zebrafish. In particular, in order to faithfully generate
human disease models, it is advantageous to develop a gene-
editing technology that enables precise and predefined sequence
modifications in the genome of a model organism.
The clustered regularly interspaced short palindromic repeats
(CRISPR)/CRISPR-associated (Cas) systems are adaptive im-
mune systems evolved in bacteria and archaea to defend against
intruding viruses and plasmid DNAs [1–3]. Previously, Jinek et al.
demonstrated that the Cas9 protein of a type II CRISPR/Cas
system from Streptococcus pyogenes is a dual RNA-guided endonu-
clease [4]. Cas9 is directed by CRISPR RNA (crRNA), which
confers target DNA recognition via sequence complementarity
and base-pairing, and a trans-activating crRNA (tracrRNA) to
mediate site-specific double-stranded DNA cleavage. Further-
more, these authors showed that in vitro Cas9 activity could be
directed by a programmable, single chimeric RNA composed of
both crRNA and tracrRNA sequences. Subsequently, various
groups used the CRISPR-Cas system to perform targeted genome
editing in cultured human cells, yeast and bacteria [5–10]. Using
zebrafish embryos, we also demonstrated that a CRISPR RNA-
guided nuclease (RGN) could be used effectively in whole
organisms by introducing non-homologous end-joining (NHEJ)-
mediated indel mutations in eight of ten endogenous genes we
targeted [11].
Our previous experiments utilized an RGN system consisting of
a synthetic single guide RNA (sgRNA) that directs the monomeric
Cas9 endonuclease from S. Pyogenes to induce site-specific DNA
double-stranded breaks (DSBs) [11]. The first 20 nucleotides (nts)
at the 59 end of the ,100-nt sgRNA are customized to
complement a genomic target DNA adjacent to a 39 NGG
sequence, referred to as the protospacer adjacent motif (PAM),
that is required for S. Pyogenes Cas9 activity (Figure 1A) [4].
Customized sgRNAs and Cas9-encoding mRNA were transcribed
in vitro from a T7 promoter and co-injected into one-cell stage
zebrafish embryos. Due to their relative ease of construction,
RGNs are appealing alternatives to other tools such as TALENs
and ZFNs for genome editing [12–14].
In the current study, we demonstrate several advances that will
significantly broaden the applicability of the RGN system. First,
we provide evidence that RGN-mediated mutations are heritably
transmitted through the zebrafish germline. Second, we show that
RGNs can be used with single-stranded oligodeoxynucleotides
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e68708
(ssODNs) to precisely introduce template-directed alterations
including single-nucleotide mutations to zebrafish. Finally, we
report on simple strategies that can be used to expand the
targeting range of our sgRNA:Cas9 system from 1 in 128 bps of
random sequence to 1 in 8 bps.
Results
High Germline Transmission Rates of RGN-induced
Mutations
To determine whether RGNs can induce heritable mutations,
we screened fish that had been injected with sgRNAs targeted to
three of the genes described in our initial report for their abilities
to transmit RGN-mediated mutations to their progeny. As shown
in Figures 1B and 2, we successfully identified founders that could
pass RGN-induced mutations through the germline in all three
genes. For the fh gene, we have previously reported the somatic
mutation efficiencies induced by injections of various concentra-
tions of sgRNA and Cas9 mRNA [11]. We found that injection of
the solution containing 12.5 ng/ml of sgRNA and 300 ng/ml of
Cas9 mRNA resulted in the highest somatic mutation rate, while it
also induced the highest amount of toxicity as shown by the
percentage of embryos that developed normally after injection
(Figure 1B). Thus, we examined if the somatic mutation rates
would have a positive correlation with the germline mutation
rates, or if Cas9 at a higher concentration might pose a negative
impact on germline transmission of the mutations. Here, we show
that all three concentrations induce heritable mutations efficiently.
In particular, for the 12.5 ng/ml of sgRNA and 300 ng/ml of Cas9
mRNA combination, we found that two out of two fish screened
were founders and 100% of their offspring carried RGN-mediated
indel mutations, suggesting that these two founders carry bialleleic
mutations in the majority of their germ cells. In addition, we could
not detect any wild-type fh allele in their fin biopsies by PCR,
suggesting that these two fish also possess 100% or nearly 100% of
bialleleic indel mutations in their tails (Figure S1).
In addition, from the fish previously injected with the RGN
targeting gsk3b, we identified three founders out of three fish
screened, one of which showed 100% germline transmission of the
gsk3b mutations (Figures 1B and 2). Genotyping of the fins of the
founders also indicated that the fish that showed 100% germline
transmission had almost complete loss of the wild-type allele
(Figure S2). For the apoea target site, we only screened one fish, and
we found that six of the nineteen embryos that we tested carried an
indel mutation (Figures 1B and 2). We have previously generated
customized TALENs targeting these three genes - fh, gsk3b and
apoea [11,15]. The TALEN target sites either overlap with or are
close to the RGN target site on the same gene (Figure S3). We
found that except for the TALENs targeting gsk3b, which were
ineffective, other RGNs and TALENs that target the same genes
Figure 1. Engineered RGNs induces heritable gene disruption. (A) Schematic illustration of the RGN system. Engineered sgRNA:Cas9 system is
depicted here based on the target sequence of the fh gene. sgRNA interacts with the complementary strand of the DNA target site harboring a 39
protospacer adjacent motif (PAM) sequence (NGG) (yellow and red underlined text, respectively). sgRNA also interacts with Cas9 endonuclease (blue
shape), resulting in DNA double-strand breaks (DSBs) at the target site. The reverse complement of the target site is highlighted as green text and the
reverse complement of the PAM site is shown as red underlined text. The potential cleavage sites of Cas9 are indicated by arrowheads. This graphic
representation is modified from a previous publication [11]. (B) Mutation frequencies in the germline induced by engineered RGNs. Fish that have
been injected with sgRNA and Cas9 mRNA at the 1-cell stage were screened for founders. The concentrations of the sgRNA and the Cas9 mRNA are as
indicated. The somatic mutation rates induced by these combinations have been reported previously [11]. The percentages of the injected embryos
that developed normally at 1 day post-fertilization are shown. The sequences of the indel mutations identified in the germline are shown in Figure 2.
doi:10.1371/journal.pone.0068708.g001
RNA-Guided Nucleases for Precise Genome Editing
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Figure 2. Germline mutation frequencies and sequences induced by engineered RGNs at the fh, gsk3b and apoea genes. Fish that had
been previously injected with engineered RGNs were screened for founders carrying heritable mutations. The tables summarize the founder
screening results. The concentrations of sgRNA and Cas9 mRNA used for microinjection are indicated on top of each table. In the last column of each
table, the numbers of embryos that possess indel mutations are shown outside of the parentheses, and the sizes of the indels are shown inside the
parentheses.+, insertion; 2, deletion. The mutant sequences identified in the germline are shown beneath each table. The wild-type sequence is
shown at the top with the target sites highlighted in yellow and the PAM sequence highlighted as red underlined text. For some genes, the target
site is on the reverse complement strand and in these cases the reverse complement of the target site is highlighted in green and the reverse
complement of the PAM site is highlighted as red underlined text. Deletions are shown as red dashes highlighted in grey and insertions as lower case
letters highlighted in blue. The net change in length caused by each indel mutation is to the right of each sequence (+, insertion; –, deletion). Note
that some alterations have both insertions and deletions of sequence and in these instances the alterations are enumerated in the parentheses.
doi:10.1371/journal.pone.0068708.g002
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showed comparable somatic and germline mutation efficiencies
(Figure S3). In addition, as has been observed in the founders
produced by highly efficient TALEN pairs [15], founders
produced by RGNs sometimes carry more than one type of
mutation at their target loci (Figure 2). These results indicate that
RGNs can efficiently induce heritable knockout mutations in
zebrafish.
Precise Targeted Insertion Using CRISPR-Cas and Single-
stranded Oligo DNA
To broaden the applications of RGNs in zebrafish, we
investigated whether these nucleases might also facilitate precise
targeted sequence modifications introduced by single-stranded
oligodeoxynucleotides (ssODNs) in the injected animals. Previous
work has shown that co-injection of TALENs and synthetic
ssODNs can result in precise sequence modification of the
zebrafish genome [16]. These ssODNs carried predefined
mutations and ,20 nts of flanking sequences homologous to the
TALEN target loci. To test whether RGNs might also be used
with ssODNs, we designed oligonucleotides containing sequences
that either share sequence identity with the sgRNAs (denoted as
‘‘sense’’) or are complementary to the sgRNAs (denoted as ‘‘anti-
sense’’) for two target sites. Each oligonucleotide also harbored a 3-
or 4-bp insertion designed to create an EcoRI site (Figure 3). We
co-injected these ssODNs with cognate sgRNA and Cas9 mRNA
into one-cell stage zebrafish embryos. Subsequently, pools of ten
injected embryos were used for amplification and subcloning of
the sgRNA target loci. These colonies were screened by PCR and
restriction digestion for the presence of the EcoRI site.
As shown in Figure 3, we found the intended precise sequence
modifications in both genomic loci as verified by sequencing,
although some of the modified alleles also contain additional indel
mutations as previously described [16]. At the fh target site, the
sense and antisense ssODN yielded 8.3% and 1.7% precise
modification, respectively (among 36 and 58 PCR amplified
sequences for the sense and antisense ssODN, respectively). At the
gsk3b target site, the sense and antisense ssODN yielded 0% and
6.3% precise modification, respectively (among 47 and 48 PCR
amplified sequences for the sense and antisense ssODN, respec-
tively). We noticed that occasionally, a part of the sequences in the
injected ssODN might be incorporated into the indels. The alleles
that did not have the targeted modification at the intended
position were not counted in our study. These data indicate that
ssODNs can be used with RGNs to create precise targeted
sequence modifications. In addition, these data suggest that there
may be locus-dependent differences between the targeting rates of
sense and antisense ssODNs. We examined the efficiencies of
RGN-mediated DNA cleavage in the presence of the ssODNs and
found that there are corresponding differences in the NHEJ-
mediated mutation rates between those groups (Table S1),
suggesting that some of the ssODNs may interfere with RGN
activity.
Precise Targeted Single-nucleotide Substitution by
CRISPR-Cas
Next, we tested whether it might be possible to create a single
bp mutation in the zebrafish genome using RGNs and ssODNs,
something that has not previously been done with ZFNs or
TALENs. To do this, we designed three ssODNs with a single nt
substitution in either the protospacer adjacent motif (PAM) or the
sgRNA target site 5 bp upstream of the PAM. We chose these
locations because previous work has shown that the PAM
sequence may be critical for cleavage and we wished to assess
whether placement in or outside of the PAM might affect the
efficiency with which we could recover the desired alterations.
As shown in Figure 4, we successfully identified alleles carrying
the desired 1-bp substitution at the target locus using all three
ssODNs, although most of them also contained additional indel
mutations. From a pool of embryos co-injected with the fh sgRNA,
the Cas9 mRNA and the ssODN carrying a 1-nt substitution in
the fh sgRNA target site, we recovered six out of 96 PCR amplified
sequences that contained the intended 1-nt substitution, one of
which had the precise sequence modification (without any
unintended indels in neighboring sequence). Previously, Jiang et al
have suggested that gRNA:Cas9 may cleave DNA sequences
followed by either NGG or NNGG [8]. Since the fh target site is
followed by 39GGGG, we synthesized two ssODNs that carry a 1-
nt substitution in the PAM sequence. With the first ssODN in
which the PAM sequence was changed to GTGG, we recovered
six out of 195 PCR amplified sequences containing the intended 1-
nt substitution, but all six also contained other unintended
sequence modifications in surrounding sequence. Nevertheless,
with the second ssODN in which the PAM sequence was changed
to GGTG, we recovered two out of 39 PCR amplified sequences
(5.1%) that had the precise 1-nt substitution without any
additional mutation. As in the targeted insertion experiments,
we detected one allele that contained a part of the ssODN
sequence in the indel without the targeted modification at the
intended position (data not shown). This allele was not counted in
our results. In sum, these results suggest that ssODNs and RGNs
can be used in concert to induce single bp substitutions in vivo.
Increasing RGN Targeting Range by Relaxing the sgRNA
59 GG Requirement.
Our current platform for sgRNA production relies on T7 RNA
polymerase-mediated in vitro transcription. As a result, all of the
sgRNAs produced using this platform must contain a GG
dinucleotide at the 59 end. This requirement together with the
requirement for the NGG PAM sequence restricts the targeting
range of RGNs to 1 in 128 bps of random DNA sequence. To
attempt to improve the targeting range of our RGN platform, we
explored whether sgRNAs could tolerate 2-nt mismatches at their
59 ends. We chose three genes – fh, tia1l and drd3, and generated
two sgRNAs per gene such that each sgRNA contained either 18
or 20 nts complementary to the genomic DNA target (denoted as
GGN18 and GGN20, respectively). These sgRNAs also had
additional GG at their 59 ends that were not complementary to the
genomic DNA targets (except for drd3 GGN20, which had only 1-
bp mismatch) (Figure 5A). As shown in Figure 5B, we found that
all but one of the sgRNAs could efficiently induce site-specific
mutations as judged by a T7 endonuclease I (T7EI) assay. We do
not know exactly why the drd3 GGN18 sgRNA failed to induce
mutations. One potential explanation is that it might self anneal
between five consecutive guanines and five consecutive cytosines in
the customized region of this sgRNA (Figure 5A).
These results demonstrate that there are two potential strategies
for broadening the targeting range of RGNs while still satisfying
the T7 promoter requirement for a 59 GG; either mismatching the
two 59 nucleotides of the gRNA (as in the GGN18 sgRNAs) or
adding two additional Gs 59 to the gRNA (as in the GGN20
sgRNAs). Thus, in theory, our RGN system can target any
genomic DNA sequence followed by 39NGG, which can be on
either strand of the DNA. In conclusion, by relaxing the 59GG
requirement for the target sequence, the targeting range of the
RGN system is increased to 1 in every 8 bps of random DNA
sequence (see Materials and Methods).
RNA-Guided Nucleases for Precise Genome Editing
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Discussion
We have previously described an engineered RGN system that
can induce DSBs and NHEJ-mediated mutations in zebrafish
embryos with high efficiency. Compared to other genome editing
platforms, including TALENs and ZFNs, the RGN system is much
simpler to implement. In this report, we provide confirmatory
evidence that RGN-induced mutations can be passed through the
zebrafish germline efficiently. In some cases, we found that 100%
of the offspring from the founder fish possessed indel mutations at
the target locus. Genotyping of the fins also suggests that these fish
may have complete loss of the wild-type allele at the target locus.
Thus, in at least two target loci, fh and gsk3b, we found that RGNs
induced abundant biallelic mutations in the injected fish. Due to
the high efficiency of the RGN system, in order to generate a
zebrafish mutant line, researchers may wish to reduce the
concentrations of the sgRNA and Cas9 mRNA if biallelic deletion
of the gene of interest will result in a lethal phenotype. These
results indicate that engineered RGNs are robust and easy-to-use
tools for generating zebrafish knockouts and open the door to
exciting potential applications for the RGN system, such as
simultaneous disruption of multiple genes or induction of
chromosomal deletions by multiplexing various sgRNAs for
microinjection.
In addition, we explored whether RGNs might facilitate the
introduction of precise genome modifications. The capability to
introduce such modifications in zebrafish is desirable because it
may facilitate the generation of human disease models, enable
Figure 3. Targeted insertions achieved by co-injection of single-stranded oligonucleotides (ssODNs) and the RGN system. The
sgRNAs targeting fh and gsk3b have been described previously [11]. For each gene, the wild-type sequence is shown at the top with the target site
highlighted in yellow and the PAM sequence highlighted as red underlined text. For some cases the target sites are highlighted in green if the target
sequences are in the reverse complement strand. The ssODNs containing 3–4 nucleotide (nt) insertions are shown beneath the wild-type sequences.
The targeted insertions are highlighted as blue underlined capital letters. The target gene sequences identified in the injected embryos are shown
beneath the ssODN sequences. Some of them contain only the precise intended changes (labeled as ‘‘precise’’ in parentheses on the right), while
others contain additional indel mutations (deletions are shown as red dashes highlighted in grey and insertions as lower case letters highlighted in
blue). The number of times each mutant sequence was isolated is shown in brackets.
doi:10.1371/journal.pone.0068708.g003
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functional analysis of different protein domains, and render
temporal or spatial control of gene deletion. Previously, two
strategies have been used for this purpose – one approach uses
double-stranded plasmid DNAs whereas the other uses ssODNs as
the donor DNA in conjunction with TALENs [16,17]. Although it
remains to be seen whether RGNs may be used to replace
TALENs in the former strategy, we find that RGNs can be used in
concert with ssODNs to create precise and predefined insertions.
We achieved 8.3% and 6.3% precise modifications for a targeted
3–4 bp insertion at the fh and gsk3b RGN target sites, respectively.
During the preparation of this manuscript, Chang et al reported a
case of imprecise genomic sequence modification while inserting
mloxP sequence into a target locus using gRNA/Cas9 and a
single-stranded DNA in zebrafish embryos [18]. In our study, we
were able to achieve precise genomic sequence modification,
without any unintended indels in flanking sequence. In addition,
we noticed that co-injection of ssODNs sometimes interfered with
the activities of RGNs irrespective of which strand of the sgRNA
genomic target site the ssODNs are homologous to. Thus, the
results suggest that it may be useful to test various ssODN
sequences and optimize the efficiency when using this approach.
We show that the use of RGNs and ssODNs in concert can also
facilitate precise single bp substitution in a zebrafish gene, which to
our knowledge is the first demonstration of an approach for
generating targeted point mutations in zebrafish. In this study, we
made a 1-nt substitution at various positions in the RGN target
locus. We attempted to change the nucleotide at the +5 position
(the fifth nucleotide counting 39 to 59 from the PAM) and two of
the nucleotides in the PAM. We observed 3.1–6.3% of PCR
amplified sequences being modified at the targeted nucleotide
using these three ssODNs (39 to 195 total sequences analyzed for
each ssODN). However, when the modification is at the+5
position, only 16% of the sequences with the intended 1-nt
substitution are precise (without any unintended mutations). None
of the sequences with the targeted modification is precise when the
PAM sequence is changed from GGGG to GTGG. Finally, both
sequences with the targeted modification that we recovered are
precise when the PAM sequence is changed from GGGG to
GGTG. It will be interesting to see whether the differences in the
rates of precisely modified alleles that we observed while targeting
different positions of the fh RGN binding site can also be observed
at other RGN target sites.
The somatic mutation rates that we observed for the targeted
insertions and single bp substitutions are within the range of
mutation efficiencies for which we and others have successfully
identified founders using ZFNs and TALENs [15,19–21]. Based
on our past experience in multiple genes, at somatic mutation rates
between 4.5 to 8%, we have successfully isolated one or more
Figure 4. Single-nucleotide substitution achieved by co-injection of single-stranded oligonucleotides (ssODNs) and the RGN
system. ssODNs carrying 1-nucleotide (nt) sequence substitutions (fh_MscI.S, fh_AgeI.S and fh_mPAM.S) were co-injected with Cas9 mRNA and the
sgRNA targeting the fh gene. The wild-type fh sequence is shown at the top with the target site highlighted in yellow and the PAM sequence
highlighted as red underlined text. The intended modifications are highlighted as blue underlined capital letters. The target gene sequences
identified in the injected embryos are shown beneath the ssODN sequences. Some of them contain only the precise intended changes (labeled as
‘‘precise’’ in parentheses on the right), while others contain additional indel mutations (deletions are shown as red dashes highlighted in grey and
insertions as lower case letters highlighted in blue). One of the identified sequence has a 1-bp point mutation (highlighted in bold and by an
underline) in addition to the intended sequence. The number of times each mutant sequence was isolated is shown in brackets.
doi:10.1371/journal.pone.0068708.g004
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founders by screening 22 or less fish ([15,19,21] and unpublished
results). In addition, at somatic mutation rates between 1 to 3%,
we and others have also been able to isolate founders by screening
more fish ([20], unpublished results and personal communica-
tions). Judging from the high rates of heritable indel mutations
mediated by the RGN system, we expect that the ssODN-
mediated modifications should be successful transmitted through
germline.
Finally, we have provided two strategies for increasing the
targeting range of our previously reported RGN system to 1 in
8 bps of random DNA by demonstrating that the requirement for
specificity of the first two nucleotides at the 59 end of sgRNAs is
low. Clearly, more work will be needed to determine what other
positions in the engineered RGNs are or are not important for
specificity. These two strategies will significantly broaden the range
of the DNA sequences that researchers will be able to target using
this simple and easy-to-use method.
ZFNs, TALENs and the CRISPR/Cas system are three
genome engineering platforms that have been successfully
exploited in zebrafish [11,15–17,19,20,22–27]. In addition, many
of the reagents and protocols for generating these customized
DNA nucleases have been made publicly available
[11,16,19,21,22,25,26,28–34]. Among these three platforms,
specific and efficient ZFNs are more challenging to engineer due
to the context-dependent activities of zinc finger motifs. On the
other hand, both TALENs and customized CRISPR/Cas can
typically be designed with the primary target sequence alone, and
they have both shown high efficiencies in general. Compared to
the CRISPR/Cas system, TALENs are more costly to generate,
but they have a better theoretical targeting range (at least three
TALENs can be made for every single bp in random DNA
sequence) [12]. Interestingly, we have observed four cases where a
gene was efficiently mutated by either TALENs or CRISPR/Cas
but not both, despite the fact that the two approaches targeted
overlapping or nearby sequences [11]. Thus, it remains to be
determined what additional factors may affect the functions of
these two systems. For example, it has been shown that TALENs
are sensitive to DNA methylation [35].
At present, there has not been a systematic or genome-wide
study of the in vivo off-target effects of TALENs or CRISPR/Cas.
However, off-target cleavage by TALENs has been reported in
several individual studies. For example, in one study, TALENs
discriminated the DNA sequence containing 6 bps but not 2 bps
of mismatch to their intended 36-bp binding sequence in the
injected zebrafish embryos [22]. In another study, off-target
cleavage at a site with 2 bps of mismatch has also been detected,
but at 20–30 fold reduced rates compared to that at the intended
target site [15]. For RGNs, previous studies of the double RNA-
guided Cas9 system have suggested that the last 12–14 nts (called
the ‘‘seed’’ sequence) in the 20-nt variable region of the crRNA are
most critical for directing Cas9 activity [4,6]. However, it seems
likely that different sgRNAs will have different degrees of
specificity and each may have its own unique profile of off-target
activities. Thus, more studies are needed in order to understand
the extent of RGN off-target effects. No matter which genome
engineering platform one chooses, it is always important to
outcross the mutant lines multiple generations to eliminate any
Figure 5. Somatic mutation frequencies induced by RGNs. (A) GGN18 and GGN20 sgRNAs and their genomic target sequences.
Sequences of the variable regions of the sgRNAs are shown here. These sgRNAs contain 1–2 nt mismatches to their genomic target sequences at the
59 end. sgRNAs bind to the reverse complement strand of the DNA that possess the genomic target sequences (see illustration in Figure 1A).
Matching genomic and sgRNA sequences are marked in red, while the mismatches are marked in blue. PAM is underlined. (B) The indel mutation
frequencies were assess using the T7EI assay.
doi:10.1371/journal.pone.0068708.g005
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unlinked mutation, conduct rescue experiments whenever possible
and validate the phenotypes with at least two independent lines.
In conclusion, this study demonstrates that engineered RGNs
can be used in a wide range of applications for precise and
heritable genome editing in zebrafish. The techniques described
herein may also be extended for use in other organisms.
Materials and Methods
Zebrafish Care
All zebrafish care and uses were approved by the Massachusetts
General Hospital Subcommittee on Research Animal Care.
Cas9 Nuclease and Single Guide RNA (sgRNA) Expression
Vectors
The Cas9 nuclease expression vector pMLM3613 used for
in vitro transcription of the Cas9 mRNA has been described
previously [11]. To construct a customized sgRNA expression
vector, pDR274 harboring a T7 promoter positioned upstream of
a partial guide RNA sequence was digested with BsaI [11]. A pair
of oligonucleotides containing the sgRNA target sequence were
annealed and cloned into this vector backbone. The annealed
oligonucleotides have overhangs that are compatible with direc-
tional cloning into the BsaI-digested pDR274 vector. The genomic
target sites and sequences of the oligonucleotides constructed in
this study are listed in Table S2. In addition, plasmids pDR279,
pDR299 and pDR338 encode sgRNAs that target sequences in
the fh, apoea and gsk3b genes, respectively, and have been described
previously [11]. pMLM3613, pDR274, pDR279, pDR299 and
pDR338 are all available from Addgene (http://www.addgene.
org/crispr-cas). Other constructs used in this study will be
provided upon request.
Production of sgRNA and Cas9 mRNA
sgRNAs were transcribed using DraI-digested sgRNA expres-
sion vectors as templates and the MAXIscript T7 kit (Life
Technologies). Cas9 mRNA was transcribed using PmeI-digested
Cas9 expression vector and the mMESSAGE mMACHINE T7
ULTRA kit (Life Technologies). Following completion of
transcription, poly(A) tailing reaction and DNase I treatment were
performed according to the manufacturer’s instructions for the
Cas9-encoding mRNA. Both the sgRNA and the Cas9-encoding
mRNA were then purified by either LiCl or ammonium acetate
precipitation and re-dissolved in RNase-free water.
Microinjection of Zebrafish Embryos
sgRNA and Cas9 mRNA were co-injected into one-cell stage
zebrafish embryos. Each embryo was injected with approximately
2 nl of solution containing 12.5 ng/ml of sgRNA and 300 ng/ml of
Cas9 mRNA unless otherwise indicated. If sgRNA:Cas9 mRNAs
were co-injected with single-stranded oligonucleotide (ssODN), a
solution containing 12.5 ng/ml of sgRNA, 200 ng/ml of Cas9
mRNA and 25–50 ng/ml of ssODN was used for microinjection.
On the next day, injected embryos were inspected under
stereoscope. Only embryos that developed normally were used
for analyses. Genomic DNA was extracted from embryos at 1–2
days after injection for either T7 Endonuclease I assays or DNA
sequencing experiments as described below.
T7 Endonuclease I (T7EI) Mutation Detection Assay
Genomic DNA was extracted from pools of 3 control or injected
embryos. Targeted genomic loci were amplified using primers
designed to anneal approximately 150 to 200 base pairs upstream
and downstream from the expected cut site and Phusion Hot Start
II high-fidelity DNA polymerase (New England Biolabs) according
to the manufacturer’s instructions. All of the primers used in this
study have been described previously [11]. PCR products were
purified with Ampure XP (Agencourt) according to the manufac-
turer’s instructions. T7 Endonuclease I assays were performed and
estimated NHEJ frequencies were calculated as previously
described [30].
Identification of Indel and Targeted Mutations
Each target locus was amplified by PCR from pooled genomic
DNA of ten injected embryos. The resulting PCR products were
cloned into the pGEM-T vector (Promega) and transformed into
bacteria. Thus, each colony represented one PCR amplified
sequence. To determine the somatic mutation rates, plasmid
DNAs isolated from single colonies were sequenced by the
Massachusetts General Hospital DNA Sequencing Core. NHEJ-
mediated indel mutation rates were determined by the numbers of
colonies containing mutant sequences divided by the total
numbers of colonies sequenced. To identify the targeted sequence
modifications introduced by ssODNs, single colonies were lyzed in
50 ml of water and used for PCR. The resulting PCR products
were screened for the presence of restriction sites indicative of
targeted sequence modifications. For all of the ssODNs used in this
study, the targeted mutations should yield new restriction enzyme
sites (as indicated in the names of the ssODNs) not present in the
wild-type sequences. Colonies possessing the targeted modifica-
tions as judged by the restriction digestion were then sequence
verified.
Founder Screen
Potential founders were crossed with wild-type zebrafish. Three
to four days post-fertilization, progeny were lysed individually in
25 microliters of the alkaline lysis buffer (25 mM NaOH, 0.2 mM
EDTA) and heated at 95uC for 30 minutes. Subsequently, the
DNA solution was neutralized using 25 microliter of the
neutralization buffer (40 mM Tris-HCl). Samples were spun at
3,000 rpm for 5 minutes, and the supernatant contained extracted
genomic DNA. In general, 12 embryos from each potential
founder were screened for the presence of indel mutations by PCR
amplifying the region surrounding the relevant RGN cleavage site
using a 6-FAM labeled fluorescent forward primer and a regular
reverse primer. The fluorescent PCR products were analyzed on
ABI 37306l DNA analyzer to evaluate their sizes [29]. For
sequence confirmation, genomic DNAs from single embryos were
amplified using targeted loci-specific primers. The PCR products
were treated with ExoSAP-IT (Affymetrix) according to the
manufacturer’s instructions before submitting for Sanger sequenc-
ing. All of the primers used in this study have been described
previously [11]. Mutant fish lines generated will be provided upon
request.
Targeting Range Calculation
Theoretically, the RGN system can target any genomic DNA
sequence followed by 39NGG, and the target site may be found on
either strand of the DNA. Thus, the targeting range is
J6J62= 1/8, which means 1 in every 8 bps of random DNA
sequence.
Supporting Information
Figure S1 Two fh founder fish showed a complete loss
of the wild-type fh allele in their fins.
(PDF)
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Figure S2 One gsk3b founder fish showed an almost
complete loss of the wild-type allele in its fins.
(PDF)
Figure S3 TALENs and RGNs for the fh, gsk3b and
apoea genes and their somatic and germline mutation
efficiencies.
(PDF)
Table S1 Mutation frequencies in the embryos co-
injected with ssODN and the sgRNA:Cas9 system.
(PDF)
Table S2 Sequences of the oligonucleotides used for
constructing sgRNA constructs in this study.
(PDF)
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